Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR Portfolio Total Stock Market ETF (Symbol: SPTM), we found that the implied analyst target price for the ETF based upon its underlying holdings is $38.42 per unit.With SPTM trading at a recent price near $34.68 per unit, that means that analysts see 10.79% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of SPTM's underlying holdings with notable upside to their analyst target prices are Selecta Biosciences Inc (Symbol: SELB), HC2 Holdings Inc (Symbol: HCHC), and Impac Mortgage Holdings, Inc. (Symbol: IMH). Although SELB has traded at a recent price of $2.04/share, the average analyst target is 373.82% higher at $9.67/share. Similarly, HCHC has 294.74% upside from the recent share price of $3.42 if the average analyst target price of $13.50/share is reached, and analysts on average are expecting IMH to reach a target price of $14.00/share, which is 273.33% above the recent price of $3.75. Below is a twelve month price history chart comparing the stock performance of SELB, HCHC, and IMH: Below is a summary table of the current analyst target prices discussed above:
|Name||Symbol||Recent Price||Avg. Analyst 12-Mo. Target||% Upside to Target|
|SPDR Portfolio Total Stock Market ETF||SPTM||$34.68||$38.42||10.79%|
|Selecta Biosciences Inc||SELB||$2.04||$9.67||373.82%|
|HC2 Holdings Inc||HCHC||$3.42||$13.50||294.74%|
|Impac Mortgage Holdings, Inc.||IMH||$3.75||$14.00||273.33%|
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc.